社会经济地位和族裔对荷兰早期乳腺癌辅助全身治疗指南依从性的影响
该研究基于荷兰癌症登记处2005年1月至2014年12月期间所有接受手术的原发单灶早期乳腺癌女性患者数据,评估社会经济地位(SES)和族裔对辅助全身治疗(AST)指南依从性的影响。共纳入104,201例患者,结果显示低SES患者接受辅助化疗(CT)过度治疗的风险较低(RR 0.67,95%CI 0.60-0.75),治疗不足的风险略高(RR 1.01,95%CI 1.00-1.01),总体接受CT的相对风险降低(RR 0.85,95%CI 0.83-0.87);SES与内分泌治疗(ET)依从性无关,族裔与CT或ET指南依从性均无关。
要点
- 低SES患者接受辅助化疗过度治疗的风险较高SES患者降低(RR 0.67,95%CI 0.60-0.75)。
- 低SES患者接受辅助化疗治疗不足的风险较高SES患者略高(RR 1.01,95%CI 1.00-1.01)。
- 未观察到族裔与辅助化疗或内分泌治疗指南依从性之间的关联。
核心结论
- 在荷兰,辅助化疗指南依从性方面观察到极小的SES差异:低SES患者较少被过度治疗,治疗不足的风险略高,导致总体接受CT的风险降低。
- 未观察到族裔与AST指南依从性之间的差异。
研究设计与样本
- 研究数据来自荷兰癌症登记处,纳入2005年1月至2014年12月期间所有接受手术的原发单灶早期乳腺癌女性患者。
- 采用泊松回归模型评估SES、族裔与辅助化疗或内分泌治疗指南依从性之间的关联,并校正临床病理变量。
- 共纳入104,201例患者进行分析。
主要发现
- 无辅助化疗指征的患者中,4%接受了辅助化疗(过度治疗);有指征的患者中,39%未接受辅助化疗(治疗不足)。
- 无辅助内分泌治疗指征的患者中,13%接受了内分泌治疗(过度治疗);有指征的患者中,14%未接受内分泌治疗(治疗不足)。
- 与高SES患者相比,中等SES和低SES患者辅助化疗治疗不足的相对风险分别为1.01(95%CI 1.00-1.01)和1.01(95%CI 1.00-1.01)。
- 与高SES患者相比,中等SES和低SES患者辅助化疗过度治疗的相对风险分别为0.85(95%CI 0.76-0.94)和0.67(95%CI 0.60-0.75)。
- 与高SES患者相比,中等SES和低SES患者总体接受辅助化疗的相对风险分别为0.94(95%CI 0.92-0.96)和0.85(95%CI 0.83-0.87)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to assess whether socioeconomic status (SES) and ethnicity affect adjuvant systemic therapy (AST) guideline adherence in early breast cancer patients in a health care setting with assumed equal access to care. METHODS: Data from all female patients surgically treated for primary unifocal early breast cancer between January 2005 and December 2014 were retrieved from the Netherlands Cancer Registry. We assessed the association between SES, ethnicity and non-adherence to adjuvant chemotherapy (CT) or endocrine therapy (ET) guideline indications with Poisson regression models, adjusting for clinicopathological variables. RESULTS: A total of 104 201 patients were included in the current analysis. Of patients without an indication, 4% and 13% received adjuvant CT or ET (overtreatment), whereas 39% and 14% of patients with an indication did not receive CT or ET (undertreatment). Medium and low SES patients were 1.01 (95% CI 1.00-1.01) and 1.01 (95% CI 1.00-1.01) times more likely to be undertreated and 0.85 (95% CI 0.76-0.94) and 0.67 (95% CI 0.60-0.75) times more likely to be overtreated with CT compared with high SES patients [resulting in an overall relative risk of CT use of 0.94 (95% CI 0.92-0.96) and 0.85 (95% CI 0.83-0.87), respectively]. No association between SES and ET guideline adherence or ethnicity and CT/ET guideline adherence was observed. CONCLUSION: In the Netherlands, minimal SES disparities in CT guideline adherence were observed: low SES patients are less likely be overtreated and marginally more likely to be undertreated with CT resulting in an overall decreased risk of receiving CT. No ethnical disparities in AST guideline adherence were observed.
引用
- Kuijer A, Verloop J, Visser O, et al. The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands. Ann Oncol. 2017. PMID: 28459994. doi:10.1093/annonc/mdx204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。